BDXBecton, Dickinson and Company
146.25USDMkt Cap: 40.30B USDP/E: 25.52Last update: 2026-05-21

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laborat…

loading…
Indicators:|

Key Statistics

Company
Market Cap40.30B USD
Enterprise Value56.76B USD
Revenue (TTM)22.23B USD
Gross Profit9.93B USD
Net Income (TTM)1.68B USD
Revenue/Share77.99 USD
Last Price146.25 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees60.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN
Valuation
P/E (Trailing)25.52
P/E (Forward)10.88
PEG1.11
EV/EBITDA9.22
EV/Revenue2.55
P/S1.81
P/B1.67
EPS (TTM)5.73
EPS (Forward)13.45
52W Range
142.6782% of range147.03
52W High147.03 USD
52W Low142.67 USD
Profitability
Gross Margin45.44%
Oper. Margin14.74%
EBITDA Margin27.70%
Profit Margin7.68%
ROE6.61%
ROA3.03%
Growth
Revenue Growth5.20%
Earnings Growth
Cash Flow & Leverage
Operating CF3.43B USD
CapEx (TTM)760.00M USD
FCF Margin20.39%
FCF Yield11.24%
Net Debt16.46B USD
Net Debt/EBITDA2.67
Balance Sheet
Debt/Equity0.76
Current Ratio0.94
Quick Ratio0.35
Book Value/Sh87.58 USD
Cash/Share2.961 USD
Dividends
Fwd Div Rate4.200 USD
Trail. Div Rate4.180 USD
Div. Yield2.87%
5Y Avg Yield1.64%
Payout Ratio72.95%
Ex-Div DateJun 9, 2026
Pay DateJun 30, 2026
Splits
Last Split1272:1000
Split DateFeb 10, 2026
Analyst Consensus
Rating2.2 (Buy)
Target (Mean)183.29 USD
Target Range156.00 USD225.00 USD
# Analysts14
Ownership
Shares Out.275.54M
Float274.75M
Insiders0.41%
Institutions99.48%
Short Interest
Short Ratio2.4d
Short % Float2.63%
Short % Out.2.31%
Shares Short6.38M
Short (prev mo.)9.49M
Technical
SMA 50152.73 (-4.2%)
SMA 200154.54 (-5.4%)
Beta0.28
S&P 52W Chg28.31%
Avg Vol (30d)1.57M
Avg Vol (10d)3.49M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)